FDA Real-Time Surveillance Not Practical For All Drugs, CDER’s Safety Surveillance Chief Says

 
• By Derrick Gingery
  
surveillance
FDA official says devoting resources to real-time surveillance of all approved drugs would not be useful. • Source: Shutterstock

More from Drug Safety

More from Pink Sheet